Literature DB >> 18180249

Three significant cases of neutropenia with etanercept.

C Wenham, K Gadsby, C Deighton.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18180249     DOI: 10.1093/rheumatology/kem332

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  6 in total

1.  Re-challenge with etanercept in patients with etanercept-induced neutropenia.

Authors:  Muhammad Haroon; Mary Daly; Sinead Harney
Journal:  Clin Rheumatol       Date:  2011-08-05       Impact factor: 2.980

Review 2.  Neutropenia in the Elderly: A Rheumatology Perspective.

Authors:  Su-Ann Yeoh; Christine Fox; Richard Hull
Journal:  Drugs Aging       Date:  2016-08       Impact factor: 3.923

Review 3.  Tocilizumab-induced neutropenia in rheumatoid arthritis patients with previous history of neutropenia: case series and review of literature.

Authors:  O Shovman; Y Shoenfeld; P Langevitz
Journal:  Immunol Res       Date:  2015-02       Impact factor: 2.829

Review 4.  Chimeric fusion proteins used for therapy: indications, mechanisms, and safety.

Authors:  Brian A Baldo
Journal:  Drug Saf       Date:  2015-05       Impact factor: 5.228

5.  The relationship between blood eosinophil count and disease activity in ankylosing spondylitis patients treated with TNF-α inhibitors.

Authors:  Gokhan Sargin; Taskin Senturk; Irfan Yavasoglu
Journal:  Saudi Pharm J       Date:  2018-05-04       Impact factor: 4.330

6.  Current Perspectives on the Role of TNF in Hematopoiesis Using Mice With Humanization of TNF/LT System.

Authors:  Violetta S Gogoleva; Kamar-Sulu N Atretkhany; Arina P Dygay; Taisiya R Yurakova; Marina S Drutskaya; Sergei A Nedospasov
Journal:  Front Immunol       Date:  2021-05-13       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.